HomeIndustriesHealthcareNovocure CEO on Fighting Aggressive Cancers, Treatment Development Pipeline
00:00
00:00
07:37
Novocure CEO on Fighting Aggressive Cancers, Treatment Development Pipeline

Novocure CEO on Fighting Aggressive Cancers, Treatment Development Pipeline

Ashley Cordova, CEO of Novocure (NVCR), joins Trading 360 after ringing the opening bell at the Nasdaq. Novocure “targets the electrical properties of cells” to fight aggressive cancers. “We are focused on extending survival,” she says, and notes recent FDA approval for lung cancer treatment and clinical trials in pancreatic and brain cancers. She also discusses the company’s balance sheet, R&D investment, and potential partnerships.

Trading 360

10 Feb 2025

SHARE

ON AIR
7:00 pm
Market On Close
education
5:00 am
Your First Trade
REPLAY
education
5:30 am
Your First Trade
REPLAY
6:00 am
The Wrap
REPLAY
7:00 am
Fast Market
REPLAY
8:00 am
Next Gen Investing
REPLAY
9:00 am
Market Overtime
REPLAY
education
9:30 am
Inside the Mind of a Trader
REPLAY
education
10:00 am
Inside the Mind of a Trader
REPLAY
education
10:30 am
Inside the Mind of a Trader
REPLAY
11:00 am
Market Overtime
REPLAY
12:00 pm
Morning Movers
1:00 pm
Morning Trade Live
3:00 pm
Trading 360
4:00 pm
Fast Market
5:00 pm
Next Gen Investing
6:00 pm
The Watch List
ON AIR
7:00 pm
Market On Close
8:30 pm
Market Overtime
REPLAY
9:00 pm
Fast Market
REPLAY
10:00 pm
Next Gen Investing
REPLAY
11:00 pm
The Wrap
REPLAY
12:00 am
Market Overtime
REPLAY
12:30 am
Market Overtime
REPLAY
1:00 am
The Wrap
REPLAY
2:00 am
Market Overtime
REPLAY
3:00 am
Fast Market
REPLAY
4:00 am
Next Gen Investing
REPLAY

Schwab Network's Newsletters

Daily insights for every investor